Title:
L-N-ISOBUTYRYL CYSTEINE (L-NIBC) -BOUND GOLD CLUSTER AU 18 (L-NIBC) 14, COMPOSITIONS AND APPLICATIONS THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/137672
Kind Code:
A1
Abstract:
L-N-isobutyryl cysteine (L-NIBC) -bound gold cluster Au 18 (L-NIBC) 14, its use for treating multiple sclerosis, Alzheimer's disease (AD), liver cirrhosis, diabetes, Parkinson's disease (PD) or glaucoma, and the use of it for manufacturing a medicament for treatment of multiple sclerosis, Alzheimer's disease (AD), liver cirrhosis, diabetes, Parkinson's disease (PD) or glaucoma. Composition and methods for treating multiple sclerosis, Alzheimer's disease (AD), liver cirrhosis, diabetes, Parkinson's disease (PD) or glaucoma.
Inventors:
SUN TAOLEI (CN)
Application Number:
PCT/CN2022/073051
Publication Date:
July 27, 2023
Filing Date:
January 20, 2022
Export Citation:
Assignee:
SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECH CO LTD (CN)
International Classes:
C07F1/00; A61P3/04; A61P3/10; A61P25/00; A61P27/06
Domestic Patent References:
| WO2021184762A1 | 2021-09-23 | |||
| WO2021226736A1 | 2021-11-18 |
Attorney, Agent or Firm:
SHANGCHENG & PARTNERS (CN)
Download PDF: